Improving Chuanxiong Rhizoma quality standards using an effect-constituent index based bioassay-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Improving Chuanxiong Rhizoma quality standards using an effect-constituent index based bioassay

Published:2023-09 Issue: Volume:233 Page:115455
ISSN:0731-7085
Container-title:Journal of Pharmaceutical and Biomedical Analysis
language:en
Short-container-title:Journal of Pharmaceutical and Biomedical Analysis

Author:

Li Chunyu,Liu Yanlu,Cao Bo,Lin Mengmeng,Wang Shiyuan,Dong Bin,Zhang Mingyu,Li Guohui

Publisher

Elsevier BV

Subject

Clinical Biochemistry,Spectroscopy,Drug Discovery,Pharmaceutical Science,Analytical Chemistry

Reference26 articles.

1. Interaction of cardiovascular nonmodifiable risk factors, comorbidities and comedications with ischemia/reperfusion injury and cardioprotection by pharmacological treatments and ischemic conditioning;Ferdinandy;Pharmacol. Rev.,2023

2. Antithrombotic strategy in secondary prevention for high-risk patients with previous acute coronary syndrome: overlap between the PEGASUS eligibility and the COMPASS eligibility in a large multicenter registry;Millesimo;Am. J. Cardiovasc. Drugs,2023

3. Chemical composition, quality control, pharmacokinetics, pharmacological properties and clinical applications of Fufang Danshen tablet: a systematic review;Zeng;J. Ethnopharmacol.,2021

4. A systematic review on the rhizome of Ligusticum chuanxiong Hort. (Chuanxiong);Chen;Food Chem. Toxicol.,2018

5. Chinese herbal injection for cardio-cerebrovascular disease: overview and challenges;Huajuan;Front. Pharmacol.,2023

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of the Pharmaceutical Activities of Chuanxiong, a Key Medicinal Material in Traditional Chinese Medicine;Pharmaceuticals;2024-08-31

2. Screening for Q-markers of Antiviral Granules based on neuraminidase inhibitors and Effect-constituent index;Arabian Journal of Chemistry;2024-02

3. Promotion of a quality standard for Paris polyphylla var. yunnanensis based on the efficacy-oriented effect-constituent index;Journal of Pharmaceutical and Biomedical Analysis;2024-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3